Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial

Mommers, Ellen; Blum, Georges-Fabrice; Gent, T.G.; Peters, Κ.; Sørdal, Terje; Marintcheva-Petrova, Maya

doi:10.1016/j.ajog.2012.08.002

Cited by 51 publications

(31 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An irregular bleeding pattern is the most frequently observed side effect and is the most common cause of early removal of ENG-R implant [16,18,[21][22][23]. In previous studies, irregular bleeding as the main reason to remove the implant early varies from 10% to 40% [20,[22][23][24]. In our study, this percentage was 17.2%.…”

Section: Discussionsupporting

confidence: 48%

Characteristics and experiences of etonogestrel-releasing contraceptive implant users in a cohort of Turkish women

2019

View full text Add to dashboard Cite

Aim: To determine the characteristics and experiences of Etonogestrel-releasing implant users in Turkish women cohort. Material and Methods: A retrospective cohort study carried out in a tertiary referral public hospital. The charts of ninetyone women who had Etonogestrel-releasing implant inserted between January 2014, and April 2016 were reviewed. Results: Of ninety-one women, over half (52.8 %) were aged ≥ thirty and a few were < twenty-five (5.5%). Only three (3.3%) women were nulliparous. Over half were university or higher graduated (54.9%) and employed (58.2%). Efficacy was the most commonly cited reasons to choose the method. Overall continuation rates were 75.0 % at twenty-five months and 50.0% at thirty-four months. Twenty-nine women removed implant before the period of use expired. Eighteen of these wanted to conceive and the other eleven discontinued because of side effects they experienced. Irregular menstrual bleeding was the most frequent side effect for removal. No woman conceived while using the method. Conclusion: Etonogestrel-releasing implant is used for its efficacy by a range of Turkish women who are especially parous, well-educated and employed. While it has high continuation rates, irregular menstrual bleeding is the commonest side effect for early removal.

show abstract

Section: Discussionsupporting

confidence: 48%

Characteristics and experiences of etonogestrel-releasing contraceptive implant users in a cohort of Turkish women

2019

View full text Add to dashboard Cite

show abstract

“…However, this modality has only been studied as a means to locate nonpalpable implants. 10,11 Implanon and Nexplanon are bioequivalent but the addition of 3% barium in Nexplanon confers the radiopaque quality. There are no published studies describing the incidence of damaged implants or comparing the incidence of damaged implants with and without the addition of barium.…”

Section: Discussionmentioning

confidence: 99%

Reports of Two Broken Nexplanon® Rods

2019

View full text Add to dashboard Cite

Damage to progestin containing contraceptive implants has been reported for Implanon® rods but there appear to be few reports of damage to Nexplanon® rods. This report describes 2 cases of Nex-planon® rod breakage in an 18-year-old female and a 25-year-old female. The literature regarding damaged progestin implants is reviewed. These reports often involve an alteration in menstrual bleeding pattern and patients frequently request removal of bent or broken implants. The overall incidence of rod breakage and impact of damaged implants on contraceptive efficacy is not clear. Evidence based guidelines to inform management of suspected damage to contraceptive implants would be helpful. In the meantime, a shared decision-making process offering removal and replacement of damaged implants would seem reasonable. (J Am Board Fam Med 2019;32:269 -271.)

show abstract

“…Initial experience with the Nexplanon® was reassuring [2]; however, ongoing clinical use has demonstrated that deep insertion with Nexplanon® still occurs and requires removal from experienced centers [3]. We present a case of a Nexplanon® inserted in the patient's biceps muscle that was successfully removed through a small incision using a combination of ultrasound and fluoroscopy guidance by interventional radiologists.…”

Section: Introductionmentioning

confidence: 90%

Removal of a Nexplanon® implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidance

et al. 2014

View full text Add to dashboard Cite

Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial

Cited by 51 publications

References 15 publications

Characteristics and experiences of etonogestrel-releasing contraceptive implant users in a cohort of Turkish women

Characteristics and experiences of etonogestrel-releasing contraceptive implant users in a cohort of Turkish women

Reports of Two Broken Nexplanon® Rods

Removal of a Nexplanon® implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidance

Contact Info

Product

Resources

About